Earth Science Tech (ETST) Other Non-Current Liabilities (2024)
Earth Science Tech's (ETST) quarterly Other Non-Current Liabilities came in at $42785.0 in Q4 2024, down 11.82% on a QoQ basis from $48522.0 in Q3 2024.
Earth Science Tech (ETST) Other Non-Current Liabilities (2024) Analysis & Trends
Earth Science Tech (ETST) has 1 years of Other Non-Current Liabilities data on file, last reported at $42785.0 in Q4 2024.
- Quarterly Other Non-Current Liabilities changed N/A year-over-year to $42785.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $42785.0 (changed N/A YoY) and the FY2024 annual result came in at $60559.0, changed N/A from the prior year.
- Other Non-Current Liabilities retreated to $42785.0 in Q4 2024, from $48522.0 in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $60559.0 in Q1 2024 to a low of $42785.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Earth Science Tech | 31.63 Mn | 28.84 Mn | 6.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 42,785.00 |
| Sep 30, 2024 | 48,522.00 |
| Jun 30, 2024 | 54,258.00 |
| Mar 31, 2024 | 60,559.00 |